Anna Kazanchyan serves as Executive at NAREK PHARMACEUTICALS, where they oversee executive responsibilities. Since joining the company, Anna Kazanchyan has executed 10 insider transactions totaling $52.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 9, 2020 involved selling 15,714 shares valued at $0.
Anna Kazanchyan currently holds 43,030 shares of NAREK PHARMACEUTICALS (N/A), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anna Kazanchyan has been a net seller of N/A stock. They have purchased $0 and sold $52.6K worth of shares.
Anna Kazanchyan's most recent insider trade was on Mar 9, 2020, when they sold 15,714 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 27, 2020 | FOMX | $0 | Award | 21,246 | $N/A | Discretionary |
| Aug 26, 2019 | FOMX | $23.1K | Sale | 7,049 | $3.27 | Discretionary |
| Jul 15, 2019 | FOMX | $1.9K | Sale | 808 | $2.31 | Discretionary |
| May 20, 2019 | FOMX | $27.7K | Sale | 10,600 | $2.61 | Discretionary |
| May 16, 2019 | FOMX | $0 | Award | 28,195 | $N/A | Discretionary |
| May 8, 2018 | FOMX | $0 | Award | 14,829 | $N/A | Discretionary |
| Nov 14, 2007 | $0 | Other | 14,000,000 | $N/A | Discretionary |
| Nov 14, 2007 | $0 | Other | 14,000,000 | $N/A | Discretionary |